Oral Semaglutide and Fatty Liver: What a 28-Week Trial Shows
Can oral semaglutide help fatty liver disease? A 28-week obesity trial found weight loss and lower liver stiffness, but fibrosis evidence remains incomplete.
NAFLD, Exercise, and Irisin: A Promising Signal, Not Proof
Explore NAFLD, exercise, and irisin: what a small randomized trial found, why muscle-liver signaling remains unproven, and what may help liver fat now.